| Name | Lenscrafters #01112 |
|---|---|
| Organization Name | Luxottica Of America Inc |
| Location | 322 Rte 4 E, Paramus, New Jersey 07652 |
| Type | Eyewear Supplier (Equipment, not the service) |
| Phone | (201) 489-8484 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Dezima Pharma, the biotechnology company developing innovative drugs in the field of dyslipidemia, announced today the initiation of a double blind, placebo controlled, Phase 2b dose ranging study of DEZ-001 (previously TA-8995), alone and in combination with statins, in order to study the effects on a wide range of lipids and other biomarkers of cardiovascular disease in patients with mild dyslipidemia.
Patients with infective endocarditis involving implanted cardiac devices experience a high rate of complications such as valve infections, heart failure, and persistent bacteremia, and high in-hospital and 1-year mortality rates, particularly if there is valve involvement, according to a study in the April 25 issue of JAMA.
The Association of Community Cancer Centers, partnered with the Avon Breast Cancer Crusade, the Cancer Support Community, and the Metastatic Breast Cancer Alliance, announced today the launch of a new online site designed to provide important educational information supporting patients diagnosed with metastatic breast cancer.
Individuals with Alzheimer's disease who are hospitalized are at risk for adverse outcomes including institutionalization, cognitive decline, and death, show study results.
› Verified 4 days ago
| NPI Number | 1265594550 |
| Organization Name | LUXOTTICA OF AMERICA INC. |
| Doing Business As | LENSCRAFTERS #1112 |
| Type | Eyewear Supplier (Equipment, not the service) |
| Address | 322 E Rte 4, Paramus, NJ 07652 |
| Phone Number | 201-489-8484 |
News Archive
Dezima Pharma, the biotechnology company developing innovative drugs in the field of dyslipidemia, announced today the initiation of a double blind, placebo controlled, Phase 2b dose ranging study of DEZ-001 (previously TA-8995), alone and in combination with statins, in order to study the effects on a wide range of lipids and other biomarkers of cardiovascular disease in patients with mild dyslipidemia.
Patients with infective endocarditis involving implanted cardiac devices experience a high rate of complications such as valve infections, heart failure, and persistent bacteremia, and high in-hospital and 1-year mortality rates, particularly if there is valve involvement, according to a study in the April 25 issue of JAMA.
The Association of Community Cancer Centers, partnered with the Avon Breast Cancer Crusade, the Cancer Support Community, and the Metastatic Breast Cancer Alliance, announced today the launch of a new online site designed to provide important educational information supporting patients diagnosed with metastatic breast cancer.
Individuals with Alzheimer's disease who are hospitalized are at risk for adverse outcomes including institutionalization, cognitive decline, and death, show study results.
› Verified 4 days ago
News Archive
Dezima Pharma, the biotechnology company developing innovative drugs in the field of dyslipidemia, announced today the initiation of a double blind, placebo controlled, Phase 2b dose ranging study of DEZ-001 (previously TA-8995), alone and in combination with statins, in order to study the effects on a wide range of lipids and other biomarkers of cardiovascular disease in patients with mild dyslipidemia.
Patients with infective endocarditis involving implanted cardiac devices experience a high rate of complications such as valve infections, heart failure, and persistent bacteremia, and high in-hospital and 1-year mortality rates, particularly if there is valve involvement, according to a study in the April 25 issue of JAMA.
The Association of Community Cancer Centers, partnered with the Avon Breast Cancer Crusade, the Cancer Support Community, and the Metastatic Breast Cancer Alliance, announced today the launch of a new online site designed to provide important educational information supporting patients diagnosed with metastatic breast cancer.
Individuals with Alzheimer's disease who are hospitalized are at risk for adverse outcomes including institutionalization, cognitive decline, and death, show study results.
› Verified 4 days ago
Paramus Pharmacy Type: Community/Retail Pharmacy Location: 61b E Ridgewood Ave, Paramus, New Jersey 07652 Phone: (201) 599-3366 | |
Cvs Pharmacy # 05300 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1000 Bergen Town Ctr, Paramus, New Jersey 07652 Phone: (201) 226-0105 | |
Cvs Pharmacy #17444 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 900 Bergen Town Ctr, Paramus, New Jersey 07652 Phone: (201) 881-7661 | |
Stop And Shop Pharmacy #878 Type: Medicare Supplier Location: 859n State Rt 17, Paramus, New Jersey 07652 Phone: (201) 445-4540 | |
The Image Recovery Center Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1 Valley Health Plz, Paramus, New Jersey 07652 Phone: (201) 634-5325 |